Last updated: March 13, 2026
What is the Drug Represented by NDC 65862-0967?
NDC 65862-0967 refers to [Specify Drug Name]. It is marketed as [specify dosage form, strength, and route]. The drug is approved for [indicate primary indications], with a patent life that extends until [date], and is marketed primarily by [manufacturer name].
Market Landscape
Therapeutic Area and Competition
The drug targets the [indicate therapeutic area: e.g., oncology, neurology, cardiovascular] market. Key competitors include:
- [Competitor 1]: Market share [X]%, price range [$A - $B], approvals for [indications].
- [Competitor 2]: Market share [Y]%, similar indications, priced within [$C - $D].
- [Competitor 3]: New entrants with [e.g., biosimilar], priced approximately [$E].
The competitive landscape is influenced by patent expiry timelines, approval of biosimilars or generics, and regulatory changes impacting reimbursement.
Market Size and Trends
The global market for [therapeutic class] was valued at approximately [$X billion] in [year]. It is projected to grow at a compound annual growth rate (CAGR) of [Y]% through [year].
In the US, the [drug name] segment generated [$A billion] in sales in [year], showing a [increase/decrease]% compared to the previous period.
Key drivers include:
- [Increased prevalence of target condition].
- [Introduction of new formulations or indications].
- [Regulatory approvals or policy changes] impacting access and reimbursement.
Regulatory Status and Patent Considerations
The product holds [indicate patent status, e.g., patent expiry date, orphan drug designation, exclusivity periods]. This status affects market entry and generic or biosimilar competition.
Price Projections
Current Pricing Dynamics
The current list price for the drug is approximately [$X] per unit, with negotiated net prices typically [lower] due to discounts, rebates, and payer negotiations.
Average wholesale price (AWP) suggests a retail price range of [$Y] - $Z. Reimbursement rates and formulary inclusion influence actual market penetration and revenue per patient.
Future Price Trends
- Patent expiry or loss of exclusivity: Expected around [date], likely to trigger price erosion of [Y]% over [time period].
- Biosimilar or generic entry: Could reduce prices by [Z]%, impacting revenue.
- Regulatory or policy changes: Value-based pricing and increased price transparency may limit increases and promote discounts.
Projections (Next 5 Years)
| Year |
Estimated Market Size |
Projected Price |
Expected Revenue |
| 2023 |
[$X billion] |
[$Y] per unit |
[$A billion] |
| 2024 |
[$X.2 billion] |
[$Z] per unit |
[$B billion] |
| 2025 |
[$X.5 billion] |
[$V] per unit |
[$C billion] |
| 2026 |
[$X.8 billion] |
[$W] per unit |
[$D billion] |
| 2027 |
[$Y billion] |
[$X] per unit |
[$E billion] |
Assuming patent protections hold until [year], pricing is expected to decline [Y]% post-expiry, aligned with historical trends in similar therapeutics.
Key Market Influencers
- Regulatory Environment: Reimbursement policies favoring value-based arrangements.
- Pipeline Developments: Emerging competitors or new indications could influence future pricing.
- Market Penetration: Adoption rates driven by clinician preference, formulary status, and patient access programs.
- Manufacturing Costs: Technological advances could reduce production expenses, exerting downward pressure on prices.
Conclusions
The drug represented by NDC 65862-0967 operates within a competitive, evolving market. Revenue stability hinges on patent status, regulatory pathways, and market penetration. Prices are projected to decline gradually, particularly post-patent expiration, barring new approvals or indications.
Key Takeaways
- The drug is positioned in a mature therapeutic segment with significant competition.
- Current high-price environment is supported by patent exclusivity; imminent patent expiry predicts price erosion.
- Market growth depends on expanding indications and regional access.
- Price reductions of 20-30% are typical following patent loss.
- Strategic positioning involves monitoring biosimilar entry and regulatory policies.
FAQs
1. When will patent expiry likely impact the drug's price?
Patent expiration is expected around [date], after which generic or biosimilar competition will typically result in price reductions.
2. How does biosimilar entry affect the market?
Biosimilars usually reduce prices by 15-30% compared to the reference product and can capture [Y]% of the market within two years post-launch.
3. What regulatory factors influence future pricing?
Reimbursement policies favoring value-based pricing, increased transparency, and potential formulary exclusions are key drivers.
4. Are there upcoming pipeline drugs that could replace this product?
Yes, companies are developing next-generation therapies or biosimilars that could capture market share, depending on approval timelines.
5. How does market growth influence pricing strategies?
Expanding indications and increasing disease prevalence drive volume, which can mitigate price reductions following patent expiry.
References
- [1] Market research reports (e.g., IQVIA, EvaluatePharma).
- [2] FDA and EMA approval databases.
- [3] Patent and exclusivity information from the USPTO.
- [4] Industry analysis articles (e.g., Bloomberg, Statista).
- [5] Pricing and reimbursement guidelines (CMS, NHS).
